PIK3CA and neoplasm: Moreover, when assessing breast cancer subgroups, PIK3R1 was predominantly underexpressed in HR-/ERBB2- and HR-/ERBB2+ tumors (p < 0.0000001) (Table 2), while PIK3CA was deregulated in only a minority of tumor samples: overexpressed in 18 (3.9%) and underexpressed in 40 (8.7%) cases (Table 1).